Novel, high-intensity exercise prescription improves muscle mass, mitochondrial function, and physical capacity in individuals with Parkinson's disease

Journal of Applied Physiology

Volumn 116, Issue 5, 2014, Pages 582-592

  Kelly, Neil A ^a,b   Ford, Matthew P ^a,c   Standaert, David G ^a,d   Watts, Ray L ^a,d   Bickel, C Scott ^a,c   Moellering, Douglas R ^a,c   Tuggle, S Craig ^a,b,f   Williams, Jeri Y ^d   Lieb, Laura ^d   Windham, Samuel T ^a,e   Bamman, Marcas M ^a,b,f  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d The University of Alabama at Birmingham   (United States)

^e Kentucky   (United States)

^f BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

High intensity exercise; Mitochondria; Muscle hypertrophy; Parkinson's disease; Resistance training

Indexed keywords

ANTIPARKINSON AGENT;

AGED; ARTICLE; BODY COMPOSITION; FEMALE; HEMODYNAMICS; HIGH-INTENSITY EXERCISE; HUMAN; KINESIOTHERAPY; MALE; METHODOLOGY; MIDDLE AGED; MITOCHONDRION; MOTONEURON; MUSCLE FATIGUE; MUSCLE HYPERTROPHY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MITOCHONDRION; MUSCLE STRENGTH; PARKINSON DISEASE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSIOLOGY; PRESCRIPTION; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; RESISTANCE TRAINING; SKELETAL MUSCLE; TREATMENT OUTCOME; VERY ELDERLY;

HIGH-INTENSITY EXERCISE; MITOCHONDRIA; MUSCLE HYPERTROPHY; PARKINSON'S DISEASE; RESISTANCE TRAINING;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; BODY COMPOSITION; EXERCISE THERAPY; FEMALE; HEMODYNAMICS; HUMANS; ISOMETRIC CONTRACTION; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MOTOR NEURONS; MUSCLE FATIGUE; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; PARKINSON DISEASE; PATIENT COMPLIANCE; PRESCRIPTIONS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84901269836     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01277.2013     Document Type: Article

References (79)

1. Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Reviews 88: 287-332, 2008.
2. Allen NE, Sherrington C, Canning CG, Fung VS. Reduced muscle power is associated with slower walking velocity and falls in people with Parkinson's disease. Parkinsonism Relat Disord 16: 261-264, 2010.
3. Allen NE, Sherrington C, Paul SS, Canning CG. Balance and falls in Parkinson's disease: a meta-analysis of the effect of exercise and motor training. Mov Disord 26: 1605-1615, 2011.
4. Archer T, Fredriksson A, Johansson B. Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol Scand 123: 73-84, 2011.
5. Atherton PJ, Babraj J, Smith K, Singh J, Rennie MJ, Wackerhage H. Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 19: 786-788, 2005.
6. Bamman MM, Petrella JK, Kim JS, Mayhew DL, Cross JM. Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans. J Appl Physiol 102: 2232-2239, 2007.
7. Bamman MM, Ragan RC, Kim JS, Cross JM, Hill VJ, Tuggle SC, Allman RM. Myogenic protein expression before and after resistance loading in 26-and 64-yr-old men and women. J Appl Physiol 97: 1329-1337, 2004.
8. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147: 755-763, 1998.
9. Bickel CS, Cross JM, Bamman MM. Exercise dosing to retain resistance training adaptations in young and older adults. Med Sci Sports Exerc 43: 1177-1187, 2011.
10. Bickel CS, Slade JM, Warren GL, Dudley GA. Fatigability and variable-frequency train stimulation of human skeletal muscles. Phys Ther 83: 366-373, 2003.
11. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint Paul H, Azulay JP, Bille F, Figarella D, Coulom F, Pellissier JF, et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 125: 95-101, 1994.
12. Brienesse LA, Emerson MN. Effects of resistance training for people with Parkinson's disease: a systematic review. J Am Med Dir Assoc 14: 236-241, 2013.
13. Burini D, Farabollini B, Iacucci S, Rimatori C, Riccardi G, Capecci M, Provinciali L, Ceravolo MG. A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease. Eura Medicophys 42: 231-238, 2006.
14. Cakit BD, Saracoglu M, Genc H, Erdem HR, Inan L. The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson's disease. Clin Rehabil 21: 698-705, 2007.
15. Carabello RJ, Reid KF, Clark DJ, Phillips EM, Fielding RA. Lower extremity strength and power asymmetry assessment in healthy and mobility-limited populations: reliability and association with physical functioning. Aging Clin Exp Res 22: 324-329, 2009.
16. Chale A, Cloutier GJ, Hau C, Phillips EM, Dallal GE, Fielding RA. Efficacy of whey protein supplementation on resistance exercise-induced changes in lean mass, muscle strength, and physical function in mobilitylimited older adults. J Gerontol A Biol Sci Med Sci 68: 682-690, 2012.
17. Coffey VG, Zhong Z, Shield A, Canny BJ, Chibalin AV, Zierath JR, Hawley JA. Early signaling responses to divergent exercise stimuli in skeletal muscle from well-trained humans. FASEB J 20: 190-192, 2006.
18. Corcos DM, Robichaud JA, David FJ, Leurgans SE, Vaillancourt DE, Poon C, Rafferty MR, Kohrt WM, Comella CL. A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord 28: 1230-1240, 2013.
19. Cruise KE, Bucks RS, Loftus AM, Newton RU, Pegoraro R, Thomas MG. Exercise and Parkinson's: benefits for cognition and quality of life. Acta Neurol Scand 123: 13-19, 2011.
20. David FJ, Rafferty MR, Robichaud JA, Prodoehl J, Kohrt WM, Vaillancourt DE, Corcos DM. Progressive resistance exercise and Parkinson's disease: a review of potential mechanisms. Parkinson's Dis 2012: 124527, 2012.
21. Devries MC, Samjoo IA, Hamadeh MJ, McCready C, Raha S, Watt MJ, Steinberg GR, Tarnopolsky MA. Endurance training modulates intramyocellular lipid compartmentalization and morphology in skeletal muscle of lean and obese women. J Clin Endocrinol Metab 2013.
22. Dibble LE, Hale TF, Marcus RL, Droge J, Gerber JP, LaStayo PC. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson's disease. Mov Disord 21: 1444-1452, 2006. (Pubitemid 44613298
23. Dibble LE, Hale TF, Marcus RL, Gerber JP, LaStayo PC. High intensity eccentric resistance training decreases bradykinesia and improves Quality Of Life in persons with Parkinson's disease: a preliminary study. Parkinsonism Relat Disord 15: 752-757, 2009.
24. Earhart GM, Falvo MJ. Parkinson disease and exercise. Compr Physiol 3: 833-848, 2013.
25. Elbaz A, Sabia S, Brunner E, Shipley M, Marmot M, Kivimaki M, Singh-Manoux A. Association of walking speed in late midlife with mortality: results from the Whitehall II cohort study. Age (Dordr) 35: 943-952, 2013.
26. Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, Dibble LE. Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 17: 693-697, 2011.
27. Fahn S, Oakes D, Shoulson I, Kieburtz K, Rudolph A, Lang A, Olanow CW, Tanner C, Marek K, Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med 351: 2498-2508, 2004.
28. Falvo MJ, Schilling BK, Earhart GM. Parkinson's disease and resistive exercise: rationale, review, and recommendations. Mov Disord 23: 1-11, 2008.
29. Finsterer J. Parkinson's syndrome and Parkinson's disease in mitochondrial disorders. Mov Disord 26: 784-791, 2011.
30. Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou JS, Marsh L, Nail L, Shulman L, Taylor CB, Working Group on Fatigue in Parkinson's Disease. Fatigue in Parkinson's disease: a review. Mov Disord 22: 297-308, 2007.
31. Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 60: 1119-1124, 2003.
32. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 23: 631-640, 2008.
33. Gregory CM, Dixon W, Bickel CS. Impact of varying pulse frequency and duration on muscle torque production and fatigue. Muscle Nerve 35: 504-509, 2007.
34. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's disease-the Fatigue Severity Scale. Eur J Neurol 9: 595-600, 2002.
35. Hirsch MA, Toole T, Maitland CG, Rider RA. The effects of balance training and high-intensity resistance training on persons with idiopathic Parkinson's disease. Arch Phys Med Rehabil 84: 1109-1117, 2003.
36. Hoppeler H. Exercise-induced ultrastructural changes in skeletal muscle. Int J Sports Med 7: 187-204, 1986.
37. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184, 1992.
38. Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med 34: 329-348, 2004.
39. Hwang WJ, Lin TS. Evaluation of fatigue in Parkinson's disease patients with stimulated single fiber electromyography. Acta Neurol Scand 104: 271-274, 2001.
40. Jacobs RA, Fluck D, Bonne TC, Burgi S, Christensen PM, Toigo M, Lundby C. Improvements in exercise performance with high-intensity interval training coincide with an increase in skeletal muscle mitochondrial content and function. J Appl Physiol (1985) 115: 785-793, 2013.
41. Janssen AJ, Trijbels FJ, Sengers RC, Smeitink JA, van den Heuvel LP, Wintjes LT, Stoltenborg-Hogenkamp BJ, Rodenburg RJ. Spectrophotometric assay for complex I of the respiratory chain in tissue samples and cultured fibroblasts. Clin Chem 53: 729-734, 2007.
42. Karvonen J, Vuorimaa T. Heart rate and exercise intensity during sports activities. Practical application. Sports Med 5: 303-311, 1988.
43. Kim JS, Kosek DJ, Petrella JK, Cross JM, Bamman MM. Resting and load-induced levels of myogenic gene transcripts differ between older adults with demonstrable sarcopenia and young men and women. J Appl Physiol 99: 2149-2158, 2005.
44. Kosek DJ, Kim JS, Petrella JK, Cross JM, Bamman MM. Efficacy of 3 days/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults. J Appl Physiol 101: 531-544, 2006.
45. Larson-Meyer DE, Newcomer BR, Hunter GR, Joanisse DR, Weinsier RL, Bamman MM. Relation between in vivo and in vitro measurements of skeletal muscle oxidative metabolism. Muscle Nerve 24: 1665-1676, 2001.
46. Leek BT, Mudaliar SR, Henry R, Mathieu-Costello O, Richardson RS. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 280: R441-R447, 2001.
47. Lima LO, Scianni A, Rodrigues-de-Paula F. Progressive resistance exercise improves strength and physical performance in people with mild to moderate Parkinson's disease: a systematic review. J Physiother 59: 7-13, 2013.
48. Lou JS. Physical and mental fatigue in Parkinson's disease: epidemiology, pathophysiology and treatment. Drugs Aging 26: 195-208, 2009.
49. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR, Group NV. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 26: 399-406, 2011.
50. Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ, Leeuwenburgh C. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 45: 2288-2301, 2013.
51. Merritt EK, Stec MJ, Thalacker-Mercer A, Windham ST, Cross JM, Shelley DP, Tuggle SC, Kosek DJ, Kim JS, Bamman MM. Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans. J Appl Physiol 115: 937-948, 2013.
52. Muhlack S, Welnic J, Woitalla D, Muller T. Exercise improves efficacy of levodopa in patients with Parkinson's disease. Mov Disord 22: 427-430, 2007. (Pubitemid 46569706
53. Parker WD Jr., Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol 26: 719-723, 1989. (Pubitemid 20011004
54. Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 30: 299-302, 2001.
55. Petrella JK, Kim JS, Mayhew DL, Cross JM, Bamman MM. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol 104: 1736-1742, 2008.
56. Petrella JK, Kim JS, Tuggle SC, Bamman MM. Contributions of force and velocity to improved power with progressive resistance training in young and older adults. Eur J Appl Physiol 99: 343-351, 2007.
57. Petrella JK, Kim JS, Tuggle SC, Hall SR, Bamman MM. Age differences in knee extension power, contractile velocity, and fatigability. J Appl Physiol 98: 211-220, 2005.
58. Petzinger GM, Fisher BE, Van Leeuwen JE, Vukovic M, Akopian G, Meshul CK, Holschneider DP, Nacca A, Walsh JP, Jakowec MW. Enhancing neuroplasticity in the basal ganglia: the role of exercise in Parkinson's disease. Mov Disord 25 Suppl 1: S141-145, 2010.
59. Pizzigalli L, Filippini A, Ahmaidi S, Jullien H, Rainoldi A. Prevention of falling risk in elderly people: the relevance of muscular strength and symmetry of lower limbs in postural stability. J Strength Cond Res 25: 567-574, 2011.
60. Rasmussen HN, Andersen AJ, Rasmussen UF. Optimization of preparation of mitochondria from 25-100 mg skeletal muscle. Anal Biochem 252: 153-159, 1997.
61. Reid KF, Fielding RA. Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev 40: 4-12, 2011.
62. Robinson TN, Wu DS, Sauaia A, Dunn CL, Stevens-Lapsley JE, Moss M, Stiegmann GV, Gajdos C, Cleveland JC Jr., Inouye SK. Slower walking speed forecasts increased postoperative morbidity and 1-year mortality across surgical specialties. Ann Surg 258: 582-590, 2013.
63. Rose MH, Lokkegaard A, Sonne-Holm S, Jensen BR. Effects of training and weight support on muscle activation in Parkinson's disease. J Electromyogr Kinesiol 2013.
64. Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM. A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151: 1319-1331, 2012.
65. Sale DG. Neural adaptation to resistance training. Med Sci Sports Exerc 20: S135-145, 1988.
66. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827, 1990.
67. Schilling BK, Pfeiffer RF, Ledoux MS, Karlage RE, Bloomer RJ, Falvo MJ. Effects of moderate-volume, high-load lower-body resistance training on strength and function in persons with Parkinson's disease: a pilot study. Parkinsons Dis 2010: 824734, 2010.
68. Shepherd D, Garland PB. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 114: 597-610, 1969.
69. Short KR, Vittone JL, Bigelow ML, Proctor DN, Coenen-Schimke JM, Rys P, Nair KS. Changes in myosin heavy chain mRNA and protein expression in human skeletal muscle with age and endurance exercise training. J Appl Physiol (1985) 99: 95-102, 2005.
70. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 67: 64-70, 2010.
71. Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE, Smith BA, Reich SG, Weiner WJ, Macko RF. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol 70: 183-190, 2013.
72. Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol 7: 528-534, 2011.
73. Stevens-Lapsley J, Kluger BM, Schenkman M. Quadriceps muscle weakness, activation deficits, and fatigue with Parkinson disease. Neurorehabil Neural Repair 26: 533-541, 2012.
74. Tanaka K, Quadros AC Jr., Santos RF, Stella F, Gobbi LT, Gobbi S. Benefits of physical exercise on executive functions in older people with Parkinson's disease. Brain Cogn 69: 435-441, 2009.
75. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25: 2649-2653, 2010.
76. Trappe S, Williamson D, Godard M. Maintenance of whole muscle strength and size following resistance training in older men. J Gerontol A Biol Sci Med Sci 57: B138-B143, 2002. (Pubitemid 34263290
77. Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 17: 61-67, 2006.
78. Winkler-Stuck K, Kirches E, Mawrin C, Dietzmann K, Lins H, Wallesch CW, Kunz WS, Wiedemann FR. Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease. J Neural Transm 112: 499-518, 2005.
79. Zigmond MJ, Cameron JL, Hoffer BJ, Smeyne RJ. Neurorestoration by physical exercise: moving forward. Parkinsonism Relat Disord 18 Suppl 1: S147-S150, 2012.